Search Results - "FRYE, F"

Refine Results
  1. 1
  2. 2

    Enzyme- and transporter-mediated beverage-drug interactions: An update on fruit juices and green tea by An, Guohua, Mukker, Jatinder Kaur, Derendorf, Hartmut, Frye, Reginald F.

    Published in Journal of clinical pharmacology (01-12-2015)
    “…Beverage–drug interactions have remained an active area of research and have been the subject of extensive investigations in the past 2 decades. The known…”
    Get full text
    Journal Article
  3. 3

    Effects of high-fructose corn syrup and sucrose on the pharmacokinetics of fructose and acute metabolic and hemodynamic responses in healthy subjects by Le, MyPhuong T, Frye, Reginald F, Rivard, Christopher J, Cheng, Jing, McFann, Kim K, Segal, Mark S, Johnson, Richard J, Johnson, Julie A

    Published in Metabolism, clinical and experimental (01-05-2012)
    “…Abstract It is unclear whether high-fructose corn syrup (HFCS), which contains a higher amount of fructose and provides an immediate source of free fructose,…”
    Get full text
    Journal Article
  4. 4

    Inhibitory Effects of Commonly Used Herbal Extracts on UDP-Glucuronosyltransferase 1A4, 1A6, and 1A9 Enzyme Activities by MOHAMED, Mohamed-Eslam F, FRYE, Reginald F

    Published in Drug metabolism and disposition (01-09-2011)
    “…The aim of this study was to investigate the effect of commonly used botanicals on UDP-glucuronosyltransferase (UGT) 1A4, UGT1A6, and UGT1A9 activities in…”
    Get full text
    Journal Article
  5. 5

    Effect of pterostilbene on in vitro drug metabolizing enzyme activity by Albassam, Ahmed A., Frye, Reginald F.

    Published in Saudi pharmaceutical journal (01-03-2019)
    “…Pterostilbene is a natural polyphenol compound found in small berries that is related to resveratrol, but has better bioavailability and a longer half-life…”
    Get full text
    Journal Article
  6. 6

    A Genetic Score Associates With Pioglitazone Response in Patients With Non-alcoholic Steatohepatitis by Kawaguchi-Suzuki, Marina, Cusi, Kenneth, Bril, Fernando, Gong, Yan, Langaee, Taimour, Frye, Reginald F

    Published in Frontiers in pharmacology (17-07-2018)
    “…Pioglitazone is used effectively to treat non-alcoholic steatohepatitis (NASH), but there is marked variability in response. This study examined whether…”
    Get full text
    Journal Article
  7. 7

    Pharmacometabolomics reveals racial differences in response to atenolol treatment by Wikoff, William R, Frye, Reginald F, Zhu, Hongjie, Gong, Yan, Boyle, Stephen, Churchill, Erik, Cooper-Dehoff, Rhonda M, Beitelshees, Amber L, Chapman, Arlene B, Fiehn, Oliver, Johnson, Julie A, Kaddurah-Daouk, Rima

    Published in PloS one (11-03-2013)
    “…Antihypertensive drugs are among the most commonly prescribed drugs for chronic disease worldwide. The response to antihypertensive drugs varies substantially…”
    Get full text
    Journal Article
  8. 8

    Concentration‐dependent response to pioglitazone in nonalcoholic steatohepatitis by Kawaguchi‐Suzuki, M., Bril, F., Kalavalapalli, S., Cusi, K., Frye, R. F.

    Published in Alimentary pharmacology & therapeutics (01-07-2017)
    “…Summary Background Pioglitazone is a safe and effective option to manage patients with type 2 diabetes and nonalcoholic steatohepatitis (NASH). However, there…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Inhibition of Intestinal and Hepatic Glucuronidation of Mycophenolic Acid by Ginkgo biloba Extract and Flavonoids by MOHAMED, Mohamed-Eslam F, FRYE, Reginald F

    Published in Drug metabolism and disposition (01-02-2010)
    “…Herb-drug interactions have received more attention in recent years because of the widespread popularity of herbal supplements. However, there are limited data…”
    Get full text
    Journal Article
  11. 11

    Current clinical evidence on pioglitazone pharmacogenomics by Kawaguchi-Suzuki, Marina, Frye, Reginald F

    Published in Frontiers in pharmacology (01-01-2013)
    “…Pioglitazone is the most widely used thiazolidinedione and acts as an insulin-sensitizer through activation of the Peroxisome Proliferator-Activated Receptor-γ…”
    Get full text
    Journal Article
  12. 12

    The Influence of Cannabidiol on the Pharmacokinetics of Methylphenidate in Healthy Subjects by Markowitz, John S., De Faria, Ludmila, Zhang, Qingchen, Melchert, Philip W., Frye, Reginald F., Klee, Brandon O., Qian, Yuli

    Published in Medical cannabis and cannabinoids (04-11-2022)
    “…Abstract Introduction: Cannabidiol (CBD) is a widely utilized nonpsychoactive cannabinoid available as an over-the-counter supplement, a component of medical…”
    Get full text
    Journal Article
  13. 13

    DHEA and DHEA-S: A Review by Kroboth, Patricia D., Salek, Firoozeh S., Pittenger, Amy L., Fabian, Tanya J., Frye, Reginald F.

    Published in Journal of clinical pharmacology (01-04-1999)
    “…Dehydroepiandrosterone (DHEA) and its sulfated metabolite DHEA‐S are endogenous hormones secreted by the adrenal cortex in response to adrenocorticotrophin…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Inhibitory effects of commonly used herbal extracts on UGT1A1 enzyme activity by Mohamed, Mohamed-Eslam F., Tseng, Tiffany, Frye, Reginald F.

    Published in Xenobiotica (01-10-2010)
    “…Commonly used herbal supplements were screened for their potential to inhibit UGT1A1 activity using human liver microsomes. Extracts screened included ginseng,…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Early atorvastatin reduces hemorrhage after acute cerebral ischemia in diabetic rats by Elewa, Hazem F, Kozak, Anna, El-Remessy, Azza B, Frye, Reginald F, Johnson, Maribeth H, Ergul, Adviye, Fagan, Susan C

    “…Ischemic stroke is a leading cause of death in the United States, and diabetes mellitus is a major risk factor for stroke. Our previous work showed that type…”
    Get more information
    Journal Article
  19. 19

    Bioequivalence revisited: Influence of age and sex on CYP enzymes by Bebia, Zourab, Buch, Shama C., Wilson, John W., Frye, Reginald F., Romkes, Marjorie, Cecchetti, Alfred, Chaves‐Gnecco, Diego, Branch, Robert A.

    Published in Clinical pharmacology and therapeutics (01-12-2004)
    “…Background and objective The activity of cytochrome P450 (CYP) enzymes, which determine the rate of elimination of lipid‐soluble drugs, demonstrates…”
    Get full text
    Journal Article
  20. 20

    Pharmacometabolomic Assessments of Atenolol and Hydrochlorothiazide Treatment Reveal Novel Drug Response Phenotypes by Rotroff, DM, Shahin, MH, Gurley, SB, Zhu, H, Motsinger‐Reif, A, Meisner, M, Beitelshees, AL, Fiehn, O, Johnson, JA, Elbadawi‐Sidhu, M, Frye, RF, Gong, Y, Weng, L, Cooper‐DeHoff, RM, Kaddurah‐Daouk, R

    “…Achieving hypertension (HTN) control and mitigating the adverse health effects associated with HTN continues to be a global challenge. Some individuals respond…”
    Get full text
    Journal Article